Can metoprolol cause bradycardia
Pro Research Analysisby 
Searched over 200M research papers
Can Metoprolol Cause Bradycardia?
Introduction to Metoprolol and Bradycardia
Metoprolol is a beta-blocker commonly prescribed to manage various cardiovascular conditions, including hypertension, angina, and heart failure. One of the known side effects of beta-blockers, including metoprolol, is bradycardia, a condition characterized by an abnormally slow heart rate.
Evidence of Metoprolol-Induced Bradycardia
Sex-Based Differences in Bradycardia Risk
Research indicates that metoprolol can cause bradycardia, with notable differences between sexes. A study from the Rotterdam Study found that women with higher plasma concentrations of metoprolol had a significantly increased risk of bradycardia compared to men. Specifically, women in the highest concentration group had a more than 15-times-higher risk of bradycardia than those in the lowest concentration group .
Comparative Risk with Other Beta-Blockers
A study comparing the incidence of emergent bradycardia between metoprolol and carvedilol found that metoprolol users had a higher adjusted risk of emergent bradycardia. The adjusted hazard ratio for metoprolol was 1.64, indicating a significantly increased risk compared to carvedilol .
Genetic Factors Influencing Bradycardia
Genetic polymorphisms, particularly those affecting the CYP2D6 enzyme, play a crucial role in metoprolol metabolism. Poor metabolizers of CYP2D6 have higher plasma concentrations of metoprolol, leading to a greater reduction in heart rate and an increased risk of bradycardia. Studies have shown that CYP2D6 poor metabolizers are at a four-fold higher risk of developing bradycardia compared to normal metabolizers Meloche2020Collett2023.
Drug-Drug Interactions
The interaction between metoprolol and CYP2D6 inhibitors, such as certain antidepressants (e.g., paroxetine and fluoxetine), can exacerbate the risk of bradycardia. These inhibitors increase metoprolol plasma levels, leading to adverse effects like bradycardia and atrioventricular block. Although some studies have shown conflicting results, the majority suggest that such drug-drug interactions can lead to significant clinical consequences Bahar2018Kurdyak2012.
Case Reports and Overdose Incidents
Several case reports have documented severe bradycardia following metoprolol overdose. For instance, a patient who ingested a large dose of metoprolol experienced life-threatening bradycardia, which required intensive medical intervention Hoeper1996Uddin2020. Another case highlighted severe sinus bradycardia after the initiation of bupropion therapy in a patient already on metoprolol, underscoring the importance of monitoring for drug interactions .
Conclusion
In summary, metoprolol can indeed cause bradycardia, with the risk influenced by factors such as sex, genetic polymorphisms, and drug-drug interactions. Women and individuals with poor CYP2D6 metabolism are particularly susceptible. Additionally, the combination of metoprolol with CYP2D6 inhibitors or in cases of overdose significantly increases the risk of bradycardia. Clinicians should consider these factors when prescribing metoprolol and monitor patients closely for signs of bradycardia.
Sources and full results
Most relevant research papers on this topic